share_log

基石药业-B(02616.HK)获Kenneth Walton Hitchner III增持26.4万股普通股股份,价值约22.14万港元

Cornerstone Pharmaceutical-B (02616.HK) received 264,000 additional shares worth HK$221,400 from Kenneth Walton Hitchner III

Futu News ·  Apr 25 17:04

On April 25, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 25, Kenneth Walton Hitchner III increased its holdings at an average price of HK$0.8387 per share on April 16$CSTONE PHARMA-B (02616.HK)$264,000 common shares worth approximately HK$221,400. After the increase in holdings, Kenneth Walton Hitchner III's latest shareholding was 1.594 million shares, and the good position ratio increased from 0.10% to 0.12%.

Additional Information: Box 28: Such Derivative Approaches the Restricted Shares Units issued and to be issued to Kenneth Walton Hitchner III proposed to the Post-IPO RSU Scheme proposed by CSStone Pharmaceuticals.

HKEXAutoNews_DA20240424E00338.png

What is disclosure of interests?

As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. The directors and top executives of a listed company must disclose their interest in shares and debentures of the listed company and the company linked to the listed company.

Why is disclosure of interests important?

Disclosure of interests allows investors to identify (1) persons who control or are capable of controlling the stock interests of listed companies, and (2) persons who may benefit from transactions involving linked entities of listed companies.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment